This summer, we welcomed over 15 brilliant high school and college students into our inaugural summer internship program. With genomic education at the forefront of Weill Cornell Medicine’s mission to care, discover and teach, the Englander...
Read more
Loredana Puca, Ph.D., and a team of scientists from the Beltran Lab and Englander Institute for Precision Medicine at Weill Cornell Medicine, developed tumor organoids that recapitulate neuroendocrine prostate cancer, a rare and aggressive...
Read more
“With your support, we can bring new therapies to patients faster. Coming from a more epidemiological background, I am very interested in the translational possibilities in the NYC area, and to explore what the role of metabolomics could be in...
Read more
Being at the forefront of precision medicine research the Englander Institute for Precision Medicine (EIPM) we are happy to announce our latest technological addition: the extension of the Hyperion module to our existing CyTOF platform –...
Read more
Researchers at the Englander Institute for Precision Medicine (EIPM) bring together basic science, medicine, DNA sequencing and big data to deliver the next generation of precision medicine; the most promising approach to tackle diseases that...
Read more
Washington may impose needless limits on genetic testing The Wall Street Journal 25 February 2018 By Dr. Olivier Elemento The federal government is threatening to limit treatment options for doctors fighting cancer. A regulatory decision due this ...
Read more
Artificial Intelligence (AI) Aids in Cancer Diagnosis An artificial intelligence (AI) program developed by Weill Cornell Medicine and NewYork-Presbyterian researchers can distinguish types of cancer from images of cells with almost 100 percent...
Read moreQuestions and answers about clonal hematopoiesis. What is hematopoiesis? Hematopoiesis refers to the body’s biological process of making blood. Our bone marrow contains blood-forming cells termed “hematopoietic stem cells.” These stem...
Read more
Patients with acute myeloid leukemia (AML) may have genetic mutations in their blood indicating they are at high risk of developing the disease about nine years before diagnosis, according to research from Weill Cornell Medicine and...
Read more Researchers can now predict the odds of experimental drugs succeeding in clinical trials, thanks to a new data-driven approach developed by Weill Cornell Medicine scientists. The method detects toxic side effects that may disqualify drugs from...
Read more
Our physicians and researchers are constantly searching for new and better ways to treat cancer. One promising development: Precision Medicine…
Read more
The institute has developed unique models to study cancer in our lab, such as growing mini tumors called ‘organoids’, using human cancer tissue that could be used to test drug responses and to personalize therapy.
Read more